Multi-drug resistant TB should be treated as a public health emergency

Experts gathered at a conference in London last week called for urgent action to tackle the global problem of multi-drug resistant tuberculosis.

Written byJacqui Wise
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

LONDON Experts gathered in London last week to call for urgent action to tackle the global problem of multi-drug resistant tuberculosis. Resistance to the commonly used anti-TB drugs is increasing rapidly in many countries of the world, particularly the former Soviet Union.

Mario Raviglione, co-ordinator of TB Strategy and Operations at the World Health Organisation said: "The situation in countries such as Estonia should be treated as a public health emergency on a par with an Ebola outbreak. In general about 2–3% of TB is multi-drug resistant but this rises to 14% of new cases in Estonia."

The meeting, 'TB drug resistance: from molecules to macro-economics', held at the Royal Society of Medicine, gathered together for the first time specialists in many different fields in order to uncover the extent of drug-resistant TB and discuss strategies to deal with it.

Tuberculosis kills two million people each year and the number ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs

Products

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform

nuclera logo

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control